Thornburg Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-103,215
Closed -$3.68M 189
2023
Q4
$3.68M Sell
103,215
-10,818
-9% -$402K 0.05% 157
2023
Q3
$5M Sell
114,033
-2,984
-3% -$146K 0.08% 139
2023
Q2
$5.78M Sell
117,017
-2,552
-2% -$118K 0.09% 129
2023
Q1
$4.96M Sell
119,569
-1,438
-1% -$59.7K 0.08% 142
2022
Q4
$5.37M Sell
121,007
-5,919
-5% -$247K 0.09% 140
2022
Q3
$4.96M Buy
126,926
+10,763
+9% +$492K 0.09% 146
2022
Q2
$4.75M Buy
116,163
+5,422
+5% +$257K 0.07% 159
2022
Q1
$7.27M Sell
110,741
-12,584
-10% -$815K 0.1% 147
2021
Q4
$8.57M Sell
123,325
-24,699
-17% -$1.8M 0.1% 142
2021
Q3
$10.3M Buy
148,024
+7,886
+6% +$607K 0.13% 137
2021
Q2
$11.1M Buy
+140,138
New +$10.2M 0.13% 132

Other funds holding ATRC

Thornburg Investment Management's ATRC Position: Q1 2024 in Review

Thornburg Investment Management sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 103,215 shares — an estimated $3.68M sold.

Thornburg Investment Management first reported a position in ATRC in Q2 2021 and held it in 11 quarters. The position peaked at $11.1M in Q2 2021. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Thornburg Investment Management reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Thornburg Investment Management sold 103,215 AtriCure shares in Q1 2024, an estimated $3.68M.
  • Thornburg Investment Management first reported a position in AtriCure in Q2 2021 and held it in 11 quarters.
  • Thornburg Investment Management's AtriCure position peaked at $11.1M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Thornburg Investment Management's 13F filing for Q1 2024, filed 13 May 2024.